QantX
  • Home
  • About us
  • For Investors
  • How we invest
  • Portfolio
  • Innovation Prize
  • News
  • Contact Us
Select Page
Climate-I

Climate-I

by Harry | Sep 10, 2024

Dynamic Therapeutics

Dynamic Therapeutics

by Harry | Jun 13, 2024

SeaCURE Carbon

SeaCURE Carbon

by Harry | Jun 10, 2024

SmartLight

SmartLight

by Harry | Jun 10, 2024

Light Trace Photonics

Light Trace Photonics

by Harry | Jun 10, 2024

« Older Entries

Latest Posts

  • SENISCA: treating age-related diseases with ground-breaking science
  • Lutra Health: integrating community and hospital eyecare
  • QantX leads £600K investment round to speed up innovation in the quantum industry
  • Supporting the Full Innovation Stack: From Lab Discovery to Global Impact
  • QantX partners with the SETsquared Partnership universities on new £300m investment vehicle

enquiries@qantx.co.uk  

Investor Area

QantX (Reference number: 954072) is an Appointed Representative of Kin Capital Partners LLP (FRN: 656789). Kin Capital Partners LLP (trading as Kin Fund Services) is authorised and regulated by the Financial Conduct Authority.

© 2022 QantX. All rights reserved. Cookie Policy | Privacy Policy

We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.OkPrivacy policy